You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intermediate-1 risk MDS

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Beijing (Hetrombopag, Stanozolol Tablets)

Not yet recruiting
  • MDS
  • Beijing, China
    Peking Union Medical College Hospital
Sep 18, 2021

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
Has Results
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

Completed
Has Results
  • Anemia
  • +5 more
  • Denver, Colorado
  • +19 more
Oct 20, 2022

Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

Completed
  • Anemia in Myelodysplastic Syndromes
  • Plantation, Florida
  • +2 more
Apr 4, 2022

MDS Trial in Bronx (Pyrimethamine)

Withdrawn
  • Myelodysplastic Syndromes
  • Bronx, New York
    Montefiore Medical Center
Sep 15, 2021

MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
  • +20 more
Dec 28, 2022

High Risk Myelodysplastic Syndrome, IPSS Risk Category Intermediate-1, Myelodysplastic Syndrome Trial in Houston (Azacitidine,

Active, not recruiting
Has Results
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

MDS Trial in France, Germany (N-Plate / romiplostim)

Completed
  • Myelodysplastic Syndromes
  • N-Plate / romiplostim
  • Annecy, France
  • +35 more
Sep 7, 2021

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

Recruiting
  • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
  • Ocala, Florida
  • +3 more
Jan 30, 2023

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

Myelodysplastic Syndrome (MDS) Trial in United States (AMV564 14-Day CIV)

Completed
  • Myelodysplastic Syndrome (MDS)
  • AMV564 14-Day CIV
  • Duarte, California
  • +4 more
Oct 11, 2021

Anemia Trial in Dresden (ACE-536)

Completed
  • Anemia
  • Dresden, Germany
    Acceleron Investigative Site
Apr 29, 2021

MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +46 more
Jan 20, 2023

MDS Trial in Dresden (ACE-536)

Completed
  • Myelodysplastic Syndromes
  • Dresden, Germany
    Acceleron Investigative Site
Apr 29, 2021

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

Low/Intermediate Risk-1 MDS Trial in Beijing (Danazol + rhTPO (recombinant human thrombopoietin injection), Danazol + sodium

Active, not recruiting
  • Low/Intermediate Risk-1 MDS
  • Danazol + rhTPO (recombinant human thrombopoietin injection)
  • Danazol + sodium chloride
  • Beijing, China
    Peking union medical college hospital
Mar 26, 2020

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

Recruiting
  • AML
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2021

MDS Trial in Chicago (Lenalidomide and azacitidine combination)

Terminated
Has Results
  • MDS
  • Lenalidomide and azacitidine combination
  • Chicago, Illinois
    Rush University Medical Center
Nov 2, 2020

MDS Trial in Worldwide (MBG453, NIS793, canakinumab)

Recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +14 more
Jan 23, 2023

Leukemia Trial in Houston (Decitabine, Azacitidine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 1, 2020

Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 12, 2021

MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Huddinge, Uppsala (NEX-18a injection,

Terminated
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • NEX-18a injection
  • Azacitidine Injection
  • Huddinge, Sweden
  • +1 more
Apr 4, 2022

Anemia Trial (Luspatercept)

Not yet recruiting
  • Anemia
  • Luspatercept
  • (no location specified)
May 26, 2023